ATE374818T1 - Identifizierung und molekulare charakterisierung von protein, die in den speicheldrüsen von zecken exprimiert werden - Google Patents

Identifizierung und molekulare charakterisierung von protein, die in den speicheldrüsen von zecken exprimiert werden

Info

Publication number
ATE374818T1
ATE374818T1 AT00934824T AT00934824T ATE374818T1 AT E374818 T1 ATE374818 T1 AT E374818T1 AT 00934824 T AT00934824 T AT 00934824T AT 00934824 T AT00934824 T AT 00934824T AT E374818 T1 ATE374818 T1 AT E374818T1
Authority
AT
Austria
Prior art keywords
ticks
salivary glands
cdna library
identification
synthesised
Prior art date
Application number
AT00934824T
Other languages
English (en)
Inventor
Edmond Godfroid
Alex Bollen
Gerard Leboulle
Original Assignee
Henogen S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henogen S A filed Critical Henogen S A
Application granted granted Critical
Publication of ATE374818T1 publication Critical patent/ATE374818T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Anesthesiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00934824T 1999-06-09 2000-06-06 Identifizierung und molekulare charakterisierung von protein, die in den speicheldrüsen von zecken exprimiert werden ATE374818T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9913425.6A GB9913425D0 (en) 1999-06-09 1999-06-09 Identification and molecular characterisation of proteins expressed in the tick salivary glands

Publications (1)

Publication Number Publication Date
ATE374818T1 true ATE374818T1 (de) 2007-10-15

Family

ID=10855024

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00934824T ATE374818T1 (de) 1999-06-09 2000-06-06 Identifizierung und molekulare charakterisierung von protein, die in den speicheldrüsen von zecken exprimiert werden
AT07109568T ATE524548T1 (de) 1999-06-09 2000-06-06 Identifizierung und molekulare charakterisierung von in den speicheldrüsen von zecken exprimierten proteinen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT07109568T ATE524548T1 (de) 1999-06-09 2000-06-06 Identifizierung und molekulare charakterisierung von in den speicheldrüsen von zecken exprimierten proteinen

Country Status (10)

Country Link
US (1) US6794166B2 (de)
EP (2) EP1187916B1 (de)
JP (1) JP2003502039A (de)
AT (2) ATE374818T1 (de)
AU (1) AU5055800A (de)
CA (1) CA2376421A1 (de)
DE (1) DE60036619T2 (de)
ES (1) ES2293900T3 (de)
GB (1) GB9913425D0 (de)
WO (1) WO2000077198A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US8277813B2 (en) 1999-06-09 2012-10-02 Edmond Godfroid Identification and molecular characterisation of proteins, expressed in the Ixodes ricinus salivary glands
US20010046499A1 (en) * 1999-12-03 2001-11-29 Kantor Fred S. Tick antigens and compositions and methods comprising them
EP1270723A1 (de) * 2001-06-27 2003-01-02 Henogen S.A. Antikomplement-Polypeptide aus den Speicheldrüsen der Zecken Ixodes Ricinus
DE60230617D1 (de) * 2001-06-27 2009-02-12 Henogen S A Antikomplement-polypeptide aus den speicheldrüsen der zecken ixodes ricinus
EP2045263A1 (de) * 2007-10-02 2009-04-08 Universite Libre De Bruxelles Identifizierung und molekulare Charakterisierung von in den Speicheldrüsen von Zecken exprimierten Speichel-Metalloproteasen
EP2055715A1 (de) * 2007-11-02 2009-05-06 Universite Libre De Bruxelles Antikomplement-Polypeptide von Ixodes ricinus
EP2123670B1 (de) * 2008-05-22 2017-08-23 Bioxodes SA Koagulationshemmendes Polypeptid
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
DK3746469T3 (da) * 2018-02-01 2024-08-19 Bioxodes Antikoagulerende proteiner og deres anvendelse til behandling af sygdomme associeret med aktiveringen af neutrofiler
EP3774877A1 (de) 2018-03-28 2021-02-17 Bioxodes Antikoagulierende fusionsproteine und verwendungen davon
CA3092992A1 (en) * 2018-04-17 2019-10-24 Technische Universitat Braunschweig Tick vaccine
WO2023023589A2 (en) * 2021-08-18 2023-02-23 The Trustees Of The University Of Pennsylvania Mrna vaccines against tick salivary proteins, and methods of using same
WO2023222871A1 (en) 2022-05-20 2023-11-23 Bioxodes Ixodes ricinus salivary gland polypeptide for preventing and treating brain inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004750A1 (en) 1993-08-09 1995-02-16 Athena Neurosciences, Inc. Tick derived protease inhibitor
JP2000083677A (ja) * 1998-09-17 2000-03-28 Bayer Ltd ダニワクチン
EP2123670B1 (de) * 2008-05-22 2017-08-23 Bioxodes SA Koagulationshemmendes Polypeptid

Also Published As

Publication number Publication date
DE60036619D1 (de) 2007-11-15
EP1187916B1 (de) 2007-10-03
JP2003502039A (ja) 2003-01-21
ES2293900T3 (es) 2008-04-01
EP1892297B1 (de) 2011-09-14
GB9913425D0 (en) 1999-08-11
EP1892297A3 (de) 2009-06-10
DE60036619T2 (de) 2008-08-07
EP1892297A2 (de) 2008-02-27
AU5055800A (en) 2001-01-02
CA2376421A1 (en) 2000-12-21
WO2000077198A2 (en) 2000-12-21
US6794166B2 (en) 2004-09-21
EP1187916A2 (de) 2002-03-20
WO2000077198A3 (en) 2001-03-15
US20020127235A1 (en) 2002-09-12
ATE524548T1 (de) 2011-09-15

Similar Documents

Publication Publication Date Title
DE60036619D1 (de) Identifizierung und molekulare charakterisierung von protein, die in den speicheldrüsen von zecken exprimiert werden
DE69841674D1 (de) Vermischen von heterologen dns-sequenzen
EP1440981A3 (de) Vollständige humane cDNS
DK372086A (da) Fremgangsmaade til rekombinant-dna-syntese af en serinproteaseinhibitor og dna-sekvenser, som er nyttige derved
NO962991D0 (no) Zink-finger-proteinderivater og fremgangsmåter
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE275630T1 (de) Fas ligand ähnliches protein, seine herstellung und verwendung
EP1074617A3 (de) Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
DE60323067D1 (de) Verfahren zur erzeugung doppelsträngiger dna mit einem 3'-einzelstranganteil und verwendungen dieser komplexe zur rekombination
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
WO2001055336A3 (en) Methods and materials relating to cd84-like polypeptides and polynucleotides
EP0824149A3 (de) Glutamine: Fructose-6-Phosphate Amidotransferase (GFAT), seine Herstellung und Verwendung
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
DK1545428T3 (da) Fremgangsmåde til formindskelse af aggregatmængder af pegylerede proteiner
ATE435914T1 (de) Induktion der blütenbildung
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
WO2001048247A3 (en) METHOD FOR GENERATION OF LONGER cDNA FRAGMENTS FROM SAGE TAGS FOR GENE IDENTIFICATION
WO2003033675A3 (en) Identification of binding partners for specific proteins
DE60230617D1 (de) Antikomplement-polypeptide aus den speicheldrüsen der zecken ixodes ricinus
WO2004109579A3 (en) Protein identification methods and systems
WO2002070699A3 (en) Cofactors of the estrogen receptor alpha and methods of use
WO2001055332A3 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
ES8700691A1 (es) Un metodo para sintetizar por adn recombinante un inhibidor de serin-proteasa con una unica cadena polipeptidica
WO2003050293A3 (en) hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
DE69731312D1 (de) Peptide spezifisch für antikörper gegen peptidconcensussequenzen aus der cs4-cfa/iprpteinfamilie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties